ForeverLabs
ServicesProvidersScienceMission
Schedule your free consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: Pelvic Floor
DTd6cp_Jrzew1kBqwMTSn.jpg
Clinical
Nov 27, 2025
1 min read
Web
Stem Cells in Clinical Trials for Pelvic Floor Disorders: a Systematic Literature Review
Authors: Stefano Manodoro, Matteo Frigerio, Marta Barba, Sara Bosio, Luigi Antonio de Vitis, Anna Maria Marconi
Pelvic FloorClinical TrialsStress urinary incontinenceAnal IncontinenceWomen's Health
AI generated image for: MSC-based therapy in female pelvic floor disorders — simplified review
Clinical
Nov 26, 2025
1 min read
Springer
MSC-based therapy in female pelvic floor disorders — simplified review
Authors: Yizhen Sima & Yisong Chen (original review published Cell & Bioscience, 2020)
Pelvic Floor
AI generated image for: Stem Cells in Clinical Trials for Pelvic Floor Disorders — Plain‑Language Summary and What It Means for Stem Cell Banking and Regenerative Medicine
Clinical
Nov 26, 2025
1 min read
Springer
Stem Cells in Clinical Trials for Pelvic Floor Disorders — Plain‑Language Summary and What It Means for Stem Cell Banking and Regenerative Medicine
Pelvic floor disorders (PFDs) — such as stress urinary incontinence (SUI), anal (fecal) incontinence, and pelvic organ prolapse — result from weakness or injury to muscles, nerves, or connective tissues of the pelvic floor. Traditional treatments (rehabilitation, surgery) often give incomplete relief. Stem cell (SC) therapy is being tested as a regenerative alternative.
Pelvic Floor

Stay in touch

Shop

Annual planLifetime planClient Login

Learn

ArticlesBlogFAQ

Careers

About usPrivacy policyPressTerms of Use

Questions

For physiciansPartner with usCareersContact us(888) 732-2375
ForeverLabs

Follow Us

FacebookXInstagramLinkedInYouTube

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.